Melanoma-differentiation antigens, which include the extensively researched melanoma-associated antigen recognized by T lymphocytes (MART-1) [113] and glycoprotein 100 (gp100) [114], were among the first tumor antigens to be identified. The gene discussed is PMEL; the disease is melanoma.